Hannibal Person1, Laurie Keefer2. 1. Department of Pediatrics, Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, One Gustave Place, Box 1656, New York, NY, 10029, USA. hannibal.person@mssm.edu. 2. Department of Medicine, Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to discuss current knowledge of brain-gut therapies (BGT) in pediatric functional gastrointestinal disorders (FGID) and inflammatory bowel disease (IBD), including their evidence base, the common psychopathology that they address, and the integration of this knowledge into medical settings. RECENT FINDINGS: Cognitive behavioral therapy (CBT), hypnotherapy (HT), mindfulness-based therapy (MBT), and exposure-based therapy (EBT) have the most data supporting their use in children, particularly in FGID, more so than in IBD. This difference is most likely because of the increased role of psychological factors in FGID, though these same factors can be seen comorbidly in IBD. Integrative BGT treatment strategies with the collaboration of clinicians across disciplines may provide the most benefit to patients. This review details our current understanding of the evidence for BGT in pediatric FGID and IBD and how they may best be used in treatment strategies.
PURPOSE OF REVIEW: The purpose of this review is to discuss current knowledge of brain-gut therapies (BGT) in pediatric functional gastrointestinal disorders (FGID) and inflammatory bowel disease (IBD), including their evidence base, the common psychopathology that they address, and the integration of this knowledge into medical settings. RECENT FINDINGS: Cognitive behavioral therapy (CBT), hypnotherapy (HT), mindfulness-based therapy (MBT), and exposure-based therapy (EBT) have the most data supporting their use in children, particularly in FGID, more so than in IBD. This difference is most likely because of the increased role of psychological factors in FGID, though these same factors can be seen comorbidly in IBD. Integrative BGT treatment strategies with the collaboration of clinicians across disciplines may provide the most benefit to patients. This review details our current understanding of the evidence for BGT in pediatric FGID and IBD and how they may best be used in treatment strategies.
Authors: Eva Szigethy; Elyse Kenney; Johanna Carpenter; Diana M Hardy; Diane Fairclough; Athos Bousvaros; David Keljo; John Weisz; William R Beardslee; Robert Noll; David Ray DeMASO Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-10 Impact factor: 8.829
Authors: Emma Louise Calvert; Lesley Anne Houghton; Patricia Cooper; Julie Morris; Peter James Whorwell Journal: Gastroenterology Date: 2002-12 Impact factor: 22.682
Authors: Rona L Levy; William E Whitehead; Lynn S Walker; Michael Von Korff; Andrew D Feld; Michelle Garner; Dennis Christie Journal: Am J Gastroenterol Date: 2004-12 Impact factor: 10.864
Authors: Arine M Vlieger; Carla Menko-Frankenhuis; Simone C S Wolfkamp; Ellen Tromp; Marc A Benninga Journal: Gastroenterology Date: 2007-09-02 Impact factor: 22.682
Authors: John V Campo; Jeff Bridge; Mary Ehmann; Sarah Altman; Amanda Lucas; Boris Birmaher; Carlo Di Lorenzo; Satish Iyengar; David A Brent Journal: Pediatrics Date: 2004-04 Impact factor: 7.124
Authors: Joy A Weydert; Daniel E Shapiro; Sari A Acra; Cynthia J Monheim; Andrea S Chambers; Thomas M Ball Journal: BMC Pediatr Date: 2006-11-08 Impact factor: 2.125